Vitreous Zonule in Primary Angle-Closure Glaucoma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30-79
SponsorPeking University People's Hospital

About this trial

This study aims to investigate the role of the vitreous zonule (VZ) in the pathogenesis of primary angle-closure glaucoma (PACG) and to explore the feasibility of three-dimensional ultrasound biomicroscopy (3D-UBM) for imaging the circumferential VZ.

This prospective, observational study will enroll patients with primary angle-closure disease (PACD), including primary angle-closure suspect (PACS), primary angle-closure (PAC), and PACG, as well as healthy controls. All participants will undergo comprehensive ophthalmic examinations, including gonioscopy, biometric measurements using IOLMaster, and UBM imaging. The study consists of three main components: (1) analysis of VZ morphology, location, number of visible quadrants, and anterior segment parameters across different age groups and axial length groups in healthy individuals, with comparisons to age-matched PACD patients; (2) development and validation of a 3D-UBM imaging system using a rotational scanning approach to reconstruct the spatial structure of the VZ; and (3) characterization of VZ features, including density and morphology, in normal eyes versus PACD eyes using 3D-UBM.

The primary outcomes include the presence, quadrant count, and morphological characteristics (vitreous zonule-pars plana angle and maximum distance) of the VZ, as well as anterior segment parameters such as lens vault, anterior chamber depth, trabecular-iris angle, and angle opening distance. By elucidating age-related and axial length-related changes in the VZ and establishing 3D-UBM as a novel imaging modality for the posterior zonular apparatus, this study seeks to provide new evidence for the mechanistic role of the VZ in angle-closure glaucoma and to identify potential imaging biomarkers for early diagnosis and risk stratification.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

The study population will be recruited from the Department of Ophthalmology at Peking University People's Hospital, a tertiary referral center in Beijing, China. Participants will include patients diagnosed with primary angle-closure disease (PACS, PAC, and PACG) and healthy controls with open angles. Patients will be identified from outpatient clinics and through routine ophthalmic examinations. Healthy controls will be recruited from volunteers undergoing routine eye examinations, as well as from hospital staff and community members. All participants will be recruited prospectively and consecutively to minimize selection bias.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

440 Participants
are grouped into 4 trial groups
Group A: Group 1 Healthy Controls
Group B: Group 2 Primary Angle-Closure Suspects (PACS)
Group C: Group 3 Primary Angle Closure
Group D: Group 4 Primary Angle Closure Glaucoma

Trial outcomes

Primary outcomes

1

Vitreous Zonule Visibility on Ultrasound Biomicroscopy

Presence and quadrant count of the VZ assessed by ultrasound biomicroscopy (UBM). VZ is defined as fibrous bands extending from the pars plana to the posterior lens equator or ciliary processes. Presence is defined as VZ visible in at least one quadrant; quadrant count ranges from 0 to 4.

Time frame
Baseline

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.